Bittersweet Decision For Prestige In Little Remedies Honey Claims Review
This article was originally published in The Tan Sheet
Executive Summary
Robitussin pediatric OTCs marketer Pfizer contends in a NAD review that the brand Little Remedies is a “therapeutic effectiveness” claim because “remedy” is a “medicine, application, or treatment that relieves or cures a disease.” NAD takes a narrower view of the brand’s use of the term.
You may also be interested in...
Bayer Will Change ‘All-Day’ Vitamin Name Following Ad Board Decision
Bayer Healthcare will change the name of itsAll-Day Energy multivitamin/multimineral product under the One-A-Day line in response to recommendations from the National Advertising Review Board
CA Tries Again To Age-Restrict Workout Supplement Sales, MA On Energy Drinks
Massachusetts legislation proposes age-restricting energy drink sales and says violating parties will face fines between $50 and $250. California bill would prohibit sales of weight loss and workout products to minors, as is already proposed in New York and Massachusetts.
Bausch Shines Planned Spin-Out, Launches First US Preservative-Free OTC Antihistamine Eye Drops
Bausch + Lomb’s Alaway Preservative-Free antihistamine eye drops launch in US, The Bausch Health Companies division planned as spin-out also recently gained South Korean approval for its Lumify OTC redness reliever drops and has submissions under review in other countries.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: